Tarsus Pharmaceuticals CEO Bobak Azamian's 2021 pay jumps 174% to $6.9M
Tarsus Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
Tarsus Pharmaceuticals reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, three executives at Tarsus Pharmaceuticals received on average a compensation package of $4.2M, a 69% increase compared to previous year.
Average pay of disclosed executives at Tarsus Pharmaceuticals
Bobak Azamian, Chief Executive Officer, received $6.9M in total, which increased by 174% compared to 2020. 88% of Azamian's compensation, or $6M, was in option awards. Azamian also received $270K in bonus, $550K in salary, as well as $22K in other compensation.
Dianne Whitfield, MSW, Chief Human Resources Officer, received a compensation package of $3.2M. 82% of the compensation package, or $2.6M, was in option awards.
Bryan Wahl, General Counsel, earned $2.6M in 2021.
Related executives
You may also like
Source: SEC filing on May 2, 2022.